Cashu
Regulatory Changes Could Boost Sarepta Therapeutics' Gene Therapy Innovations
2 days ago
Stocks
Health Care
srpt
Sarepta Therapeutics
NASDAQ: SRPT
-0.09 (-0.51%)
17.57
USD
At close at Mar 11, 20:07 UTC
Latest Sarepta Therapeutics News
benzinga.com
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
2 days ago
benzinga.com
Why Is uniQure Stock Skyrocketing Monday?
2 days ago
cnbc.com
FDA reversals leave investors worrying about the fates of other experimental drugs
5 days ago
cnbc.com
'In a bit of chaos': FDA watchers warn about agency hemorrhaging staff and the risk to America's health
8 days ago
benzinga.com
Sarepta Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
12 days ago
benzinga.com
Sarepta CEO To Jump Ship After 'Tumultuous' Year
13 days ago
benzinga.com
Earnings Scheduled For February 25, 2026
14 days ago
benzinga.com
Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Wednesday?
3 months ago
benzinga.com
Dyne's Duchenne Drug Shows Strong Muscle And Function Improvements
3 months ago
benzinga.com
Solid Biosciences: Better Positioned To Compete In DMD Gene Therapy, Says Bullish Analyst
3 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.